Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 7930-7938

  Spencer, John S ^a   Dockrell, Hazel M ^b   Kim, Hee Jin ^a   Marques, Maria A M ^a   Williams, Diana L ^c   Martins, Marcia V S B ^d,f   Martins, Marcio L F ^d   Lima, Monica C B S ^d,e   Sarno, Euzenir N ^d   Pereira, Geraldo M B ^d,e   Matos, Haroldo ^e   Fonseca, Leila S ^f   Sampaio, Elisabeth P ^d   Ottenhoff, Thomas H M ^g   Geluk, Annemieke ^g   Cho, Sang Nae ^h   Stoker, Neil G ⁱ   Cole, Stewart T ^j   Brennan, Patrick J ^a   Pessolani, Maria C V ^d  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Yonsei University College of Medicine   (South Korea)

ⁱ ROYAL VETERINARY COLLEGE   (United Kingdom)

^j INSTITUT PASTEUR   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; PROTEIN ML0008; PROTEIN ML0126; PROTEIN ML1057; PROTEIN ML2567; PROTEIN P 81; PROTEIN P39; PROTEIN P40; PROTEIN P42; PROTEIN P44; PROTEIN P47; PROTEIN P48; PROTEIN P49; PROTEIN P51; PROTEIN P52; PROTEIN P53; PROTEIN P54; PROTEIN P57; PROTEIN P63; PROTEIN P70; PROTEIN P73; PROTEIN P74; PROTEIN P80; PROTEIN P82; PROTEIN P83; RECOMBINANT PROTEIN; SYNAPTOPHYSIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CELL SPECIFICITY; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CONTROL; EARLY DIAGNOSIS; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; EPITOPE MAPPING; GENE IDENTIFICATION; HEALTH SURVEY; HOUSEHOLD; IMMUNOREACTIVITY; INCIDENCE; LEPROSY; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 29144456599     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.7930     Document Type: Article

References (40)

1. World Health Organization. 2003. Leprosy elimination campaigns: impact on case detection. Wkly. Epidemiol. Rec. 78: 9-16.
2. World Health Organization. 2002. Leprosy elimination campaigns. Wkly. Epidemiol. Rec. 77: 17-20.
3. World Health Organization. 2002. Leprosy: global situation. Wkly. Epidemiol. Rec. 77: 1-8.
4. Cho, S. N., S. H. Kim, R. V. Cellona, G. P. Chan, T. T. Fajardo, G. P. Walsh, and J. D. Kim. 1992. Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines. Lepr. Rev. 63: 12-20.
5. Chin-a-Lien, R. A., W. R. Faber, M. M. van Rens, D. L. Leiker, B. Naafs, and P. R. Klatser. 1992. Follow-up of multibacillary leprosy patients using a phenolic glycolipid-T-based ELISA: do increasing ELlSA-values after discontinuation of treatment indicate relapse? Lepr. Rev. 63: 21-27.
6. Buhrer-Sekula, S., H. L. Smits, G. C. Gussenhoven, J. Van Leeuwen, S. Amador, T. Fujiwara, P. R. Klatser, and L. Oskam. 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J. Clin. Microbiol. 41: 1991-1995.
7. Brennan, P. J. 2000. Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation. Lepr. Rev. 71(Suppl.): S50-S54.
8. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
9. Cole, S. T., K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Wheeler, N. Honore, T. Garnier, C. Churcher, D. Harris, et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409: 1007-1011.
10. Altschul, S. F., T. L. Madden, A. A. Schaffer J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
11. Spencer, J. S., H. J. Kim, A. M. Marques, M. Gonzalez-Juarerro, M. C. B. S. Lima, V. D. Vissa, R. W. Truman, M. L. Gennaro, S-N. Cho, S. T. Cole, and P. J. Brennan. 2004. Comparative analysis of B- and T-cell epitopes of Mycobacterium ieprae and Mycobacterium tuberculosis culture nitrate protein 10. Infect. Immun. 72: 3161-3170.
12. Marques, M. A. M., S. Chitale, P. J. Brennan, and M. C. V. Pessolani. 1998. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun. 66: 2625-2631.
13. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci. USA 76: 4350-4354.
14. Truman, R. W., and J. L. Krahenbuhl. 2001. Viable Mycobacterium leprae as a research reagent. Int. J. Lepr. Other Mycobact. Dis. 69: 1-12.
15. Williams, D. L., Oby-Robinson, S., Pittman, T. L., and D. M. Scollard. 2003. Purification of Mycobacterium leprae RNA for gene expression analysis directly from biopsy specimens of leprosy patients. Biotechniques 35: 534-541.
16. Garnier, T., K. Eiglmeier, J. C. Camus, N. Medina, H. Mansoor, M. Pryor, S. Duthoy, S. Grondin, C. Lacroix, C. Monsempe, et al. 2003. The complete genome sequence of Mycobacterium bovis. Proc. Natl Acad. Sci. USA 100: 7877-7882.
17. Geluk, A., K. E. van Meijgaarden, K. L. Franken, Y. W. Subronto, B. Wieles, S. M. Arend, E. P. Sampaio, T. de Boer, W. R. Faber, B. Naafs, and T. H. Ottenhoff. 2002. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T cell cross-reactivity with Mycobacterium tuberculosis. Infect. Immun. 70: 2544-2548.
18. Geluk, A., K. E. van Meijgaarden, K. L. M. C. Franken, B. Wieles, S. M. Arend, W. R. Faber, B. Naafs, and T. H. M. Ottenhoff. 2004. Immunological cross-reactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand. J. Immunol. 59: 66-70.
19. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde. N. Persaud, W. Trigona, T. M. Fu, E. Sinclair, et al. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255: 27-40.
20. Mitsuda, K. 1919. On the value of a skin reaction to a suspension of leprosy nodules. Jap. J. Der. Urol. 19: 697-708.
21. Fernandez, J. M. M. 1940. The early reaction induced by lepromin. Int. J. Lepr. 8: 1-14.
22. Draper, P. 1979. Protocol 1/79: purification of M. leprae. In Annex 1 of the Enlarged Steering Committee for Research on the Immunology of Leprosy (IMMLEP) Meeting, February 7-8. World Health Organization, Geneva, p. 4.
23. Shepard, C. C., P. Draper, R. J. W. Rees, and C. Lowe. 1980. Effect of purification on the immunogenicity of Mycobacterium leprae. Br. J. Exp. Path. 61: 376-379.
24. Rivoire, B., M. C. V. Pessolani, C. M. Bozic, S. W. Hunter, S. A. Hefta, V. Mehra, and P. J. Brennan. 1994. Chemical definition, cloning, and expression of the major protein of the leprosy bacillus. Infect. Immun. 62: 2417-2425.
25. Hunter, S. W., B. Rivoire, V. Mehra, B. R. Bloom, and P. J. Brennan. 1990. The major native proteins of the leprosy bacillus. J. Biol. Chem. 265: 14065-14068.
26. Marques, M. A. M., B. J. Espinosa, E. K. X. da Silveira, M. C. V. Pessolani, A. Chapeaurouge, J. Perales, K. M. Dobos, J. T. Belisle, J. S. Spencer, and P. J. Brennan. 2004. Continued proteomic analysis of Mycobacterium leprae subcellular fractions. Proteomics 4: 2942-2953.
27. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis infection in interferon ãgene-disrupted mice. J. Exp. Med. 178: 2243-2247.
28. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162: 5407-5416.
29. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178: 1274-1282.
30. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520-1523.
31. Arend, S. M., P. Andersen, K. E. van Meijgaarden, R. L. Skjot, Y. W. Subronto, J. T. van Dissel, and T. H. Ottenhoff. 2000. Detection of active tuberculosis infection by T cell responses to early secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181: 1850-1854.
32. van Pinxteren, L. A., P. Ravn, E. M. Agger, J. Pollock, and P. Andersen. 2000. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol. 7: 155-160.
33. Ewer, K., J. Deeks, L. Alvarez, G. Bryant, S. Waller, P. Andersen, P. Monk, and A. Lalvani. 2003. Comparison of T cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168-1173.
34. Arend, S. M., A. Geluk, K. E. van Meijgaarden, J. T. van Dissel, M. Theisen, P. Andersen, and T. H. Ottenhoff. 2000. Antigenic equivalence of human T cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect. Immun. 68: 3314-3321.
35. Scarpellini, P., S. Tasca, L. Galli, A. Beretta, A. Lazzarin, and C. Fortis. 2004. Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J. Clin. Microbiol. 42: 3469-3474.
36. Okkels, L. M., I. Brock, F. Follmann, E. M. Agger, S. M. Arend. T. H. M. Ottenhoff, F. Oftung, I. Rosendrands, and P. Andersen. 2003. PPE protein (Rv3873) from DNA segment RDl of Mycobacterium tuberculosis: strong recognition of both specific T cell epitopes and epitopes conserved within the PPE family. Infect. Immun. 71: 6116-6123.
37. Liu, X.-Q., D. Dosanjh, H. Varia, K. Ewer, P. Cockle, G. Pasvol, and A. Lalvani. 2004, Evaluation of T cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect. Immun. 72: 2574-2581.
38. Brock, I., K. Weldingh, E. M. S. Leyten, S. M. Arend, P. Ravn, and P. Andersen. 2004. Specific T cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J. Clin. Microbiol. 42: 2379-2387.
39. Cockle, P. J., S. V. Gordon, A. Lalvani, B. M. Buddle, R. G. Hewinson, and H. M. Vordermeier. 2002. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70: 6996-7003.
40. + T cell response. J. Exp. Med. 201: 1555-1565.